U.S. Research Leadership at a Crossroads — The Impact of Reducing NIH Indirect-Cost Coverage 💡📉🔍
Read Full Article
#USResearchLeadership #NIHIndirectCosts #ResearchFunding #InnovationInScience #HealthResearchChallenges
Read Full Article
#USResearchLeadership #NIHIndirectCosts #ResearchFunding #InnovationInScience #HealthResearchChallenges
The New England Journal of Medicine
U.S. Research Leadership at a Crossroads — The Impact of Reducing NIH Indirect-Cost Coverage | NEJM
The Trump administration’s proposed 15% cap on indirect-cost rates for National Institutes
of Health grants risks upending the paradigm that underpins American leadership in
medical research.
of Health grants risks upending the paradigm that underpins American leadership in
medical research.